Clinical justification of acute respiratory distress syndrome and other pulmonary complications in COVID-19
Автор: Sodikova D.T.
Журнал: Экономика и социум @ekonomika-socium
Рубрика: Основной раздел
Статья в выпуске: 11-1 (90), 2021 года.
Бесплатный доступ
Acute respiratory distress syndrome —ARDS) is an acute diffuse inflammatory lesion of the lung parenchyma that develops as a non-specific reaction to various damaging factors and leads to the formation of acute respiratory failure (ODN) (as a component of multiple organ failure) due to a violation of the structure of lung tissue and a decrease in the mass of aerated lung tissue This article concludes that severe acute respiratory distress syndrome caused by the novel coronavirus-2 (COVID-19) is considered an emergency pandemic of respiratory diseases, the clinical picture of this infection often meets the criteria of acute respiratory distress syndrome (ARDS) with progressive stress leading to death.
COVID-19, acute respiratory distress syndrome, pulmonary complications.
Короткий адрес: https://sciup.org/140261200
IDR: 140261200
Список литературы Clinical justification of acute respiratory distress syndrome and other pulmonary complications in COVID-19
- Vartanyan A.A., Kosorukov V.S. Pyroptosis - an inflammatory form of cell death // Clinical oncohematology. — 2020. - Vol. 13. - No. 2. - Pp. 129-135.
- Zaitsev A.A., Chernov S.A., Stets V.V., et al. Algorithms for the management of patients with a new coronavirus infection CID-19 in the hospital. Methodological recommendations. - M.: N.N. Burdenko State Pedagogical University, 2020. - 16 p.
- Samsonova M.V., Mikhaleva L.M., Chernyaev A.L., et al. Pathological anatomy of the lungs COVID-19 at: atlas / Edited by O.V. Zairatyants. - Ryazan: Ryazan Regional Printing House, 2020. - 57 p.
- Tsinserling V.A., Vashukova M.A., Vasilyeva M.V., et al. Questions of pathomorphogenesis of a new coronavirus infection (COVID-19)// Journal of Infectology.- 2020. - Vol.12. - No. 2. - p.5-11.
- Member of Parliament Ocaranza, Riquelme Ja, Garcia L. et al. Counterregulatory renin-angiotensin system in cardiovascular diseases. Nat Revolver Cardiol. 2020; 17(2): 116-129. doi: 10.1038/s41569-019-0244-8.
- Guo T, Fan Wu, Chen M, etc. Cardiovascular consequences of deaths in patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020; e201017.doi: 10.1001/Jamacardio. 2020.1017.
- Zhang X, Penninger J.M., Li Wu et al. Angiotensin converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and a potential therapeutic target. Intensive care Med.2020; 46:586-590. doi: 10.1007/s00134/doi: 10.1007/s00134-020-05985-9.